{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T22:40:39Z","timestamp":1740350439002,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1985,10,1]],"date-time":"1985-10-01T00:00:00Z","timestamp":496972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1985,10,1]],"date-time":"1985-10-01T00:00:00Z","timestamp":496972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[1985,10]]},"DOI":"10.1007\/bf03189762","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T03:21:25Z","timestamp":1281064885000},"page":"333-341","source":"Crossref","is-referenced-by-count":5,"title":["The disposition and elimination of stereoisomeric pairs of thioridazine 5-sulfoxide in the rat"],"prefix":"10.1007","volume":"10","author":[{"given":"P. W.","family":"Hale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Melethil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Poklis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03189762_CR1","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1523\/JNEUROSCI.03-08-01607.1983","volume":"3","author":"L. Chiodo","year":"1983","unstructured":"Chiodo L. and Bunney B. (1983): Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci.,3, 1607\u20131619.","journal-title":"J. Neurosci."},{"key":"BF03189762_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/0024-3205(83)90929-3","volume":"32","author":"F. White","year":"1983","unstructured":"White F. and Wang R. (1983): Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sei.,32, 983\u2013993.","journal-title":"Life Sei."},{"key":"BF03189762_CR3","first-page":"587","volume":"21","author":"R. Axelsson","year":"1977","unstructured":"Axelsson R. (1977): On the serum concentrations a nd antipsychotic effects of thioridazine, thioridazine sidechain sulfoxide and thioridazine side-chain sulfone in chronic psychotic patients. Curr. Ther. Res.,21, 587\u2013605.","journal-title":"Curr. Ther. Res."},{"key":"BF03189762_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF00562905","volume":"11","author":"F. Vanderheeren","year":"1977","unstructured":"Vanderheeren F. and Muusze R. (1977): Plasma levels and half-lives of thioridazine and some of its metabolites. Eur. J. Clin. Pharmacol.,11, 135\u2013140.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF03189762_CR5","first-page":"520","volume":"7","author":"A. Sugerman","year":"1965","unstructured":"Sugerman A. (1965): Comparison of TPS-23 and thioridazine in chronic schizophrenic patients. Curr. Ther. Res.,7, 520\u2013527.","journal-title":"Curr. Ther. Res."},{"key":"BF03189762_CR6","first-page":"263","volume":"11","author":"H. Freeman","year":"1969","unstructured":"Freeman H., Rivera H., Oktem M. and Oktem N. (1969): A double blind comparison of therapeutic efficacy of mesoridazine versus chlorpromazine. Curr. Ther. Res.,11, 263\u2013270.","journal-title":"Curr. Ther. Res."},{"key":"BF03189762_CR7","first-page":"687","volume":"18","author":"E. Martensson","year":"1975","unstructured":"Martensson E., Nyberg G. and Axellson R. (1975): Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients. Curr. Ther. Res.,18, 687\u2013700.","journal-title":"Curr. Ther. Res."},{"key":"BF03189762_CR8","first-page":"125","volume-title":"Cardiac Toxicology","author":"L. Weiss","year":"1981","unstructured":"Weiss L. (1981): The cardiotoxicity of neuroleptic and tricyclic antidepressant drugs. In: Cardiac Toxicology (Tibor Balazs, ed.), Volume II, pp. 125\u2013145, CRC Press, Boca Raton."},{"key":"BF03189762_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/jps.2600720610","volume":"72","author":"E. Juenge","year":"1983","unstructured":"Juenge E., Wells C., Green D., Forrest I. and Shoolery J. (1983): Synthesis, isolation and characterization of two stereoisomeric ring sulfoxides of thioridazine. J. Pharm. Sei.,72, 617\u2013621.","journal-title":"J. Pharm. Sei."},{"key":"BF03189762_CR10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jat\/6.5.250","volume":"6","author":"A. Poklis","year":"1982","unstructured":"Poklis A., Wells C. and Juenge E. (1982): Thioridazine and its metabolites in postmortem blood, including two stereoisomeric ring sulfoxides. J. Anal. Toxicol.,6, 250\u2013252.","journal-title":"J. Anal. Toxicol."},{"key":"BF03189762_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jps.2600670208","volume":"67","author":"L. Gottschalk","year":"1978","unstructured":"Gottschalk L., Dinovo E., Biener R. and Nandi B. (1978): Plasma concentrations of thioridazine metabolites and ECG abnormalities. J. Pharm. Sei.,67, 155\u2013157.","journal-title":"J. Pharm. Sei."},{"key":"BF03189762_CR12","first-page":"463","volume":"28","author":"R. Axelsson","year":"1980","unstructured":"Axelsson R. and Martensson E. (1980): Side effects of thioridazine and their relationship with the serum concentrations of the drug and its main metabolites. Curr. Ther. Res.,28, 463\u2013489.","journal-title":"Curr. Ther. Res."},{"key":"BF03189762_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-4274(84)90215-7","volume":"21","author":"P. Hale","year":"1984","unstructured":"Hale P. and Poklis A. (1984): Thioridazine 5-sulfoxide cardiotoxicity in the isolated, perfused rat heart. Toxicol. Lett.,21, 1\u20138.","journal-title":"Toxicol. Lett."},{"key":"BF03189762_CR14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3181\/00379727-134-34784","volume":"734","author":"S. Curry","year":"1970","unstructured":"Curry S., Derr J. and Maling H. (1970): The physiological disposition of chlorpromazine in the rat and dog. Proc. Soc. Exp. Biol. Med.,734, 314\u2013318.","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF03189762_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0378-4347(00)85176-2","volume":"336","author":"P. Hale","year":"1984","unstructured":"Hale P. and Poklis A. (1984a): Determination of diastereoisomeric pairs of thioridazine 5-sulfoxide by high performance liquid chromatography. J. Chromatogr. Biomed. Appl.,336, 452\u2013455.","journal-title":"J. Chromatogr. Biomed. Appl."},{"key":"BF03189762_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2307\/2529651","volume":"30","author":"C.M . Metzler","year":"1974","unstructured":"Metzler C.M., Elfring G.L. and McEwen A.J. (1974): A package of computer programs for pharmacokinetic modeling. Biometrics,30, 562\u2013563.","journal-title":"Biometrics"},{"key":"BF03189762_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF01061504","volume":"2","author":"H.G. Boxenbaum","year":"1974","unstructured":"Boxenbaum H.G., Riegelman S. and Elashoff R.M. (1974): Statistical estimations in pharmacokinetics. J. Pharmacokinet. Biopharm.,2, 123\u2013148.","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"BF03189762_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF01117450","volume":"6","author":"K. Yamaoka","year":"1978","unstructured":"Yamaoka K., Nakagawa T. and Uno T. (1978): Application of Akaike\u2019s Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm.,6, 165\u2013175.","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"BF03189762_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0002-9149(63)90035-3","volume":"77","author":"B. Maden","year":"1963","unstructured":"Maden B. and Pendse V. (1963): Antiarrhythmic activity of thioridazine hydrochloride (Mellaril). Am. J. Cardio.,77, 78\u201381.","journal-title":"Am. J. Cardio."},{"key":"BF03189762_CR20","first-page":"549","volume":"89","author":"H. Kelly","year":"1963","unstructured":"Kelly H., Fay J. and Laverty S. (1963): Thioridazine hydrochloride (Mellaril): its effects on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. Can. Med. Assoc. J.,89, 549\u2013554.","journal-title":"Can. Med. Assoc. J."},{"key":"BF03189762_CR21","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1001\/jama.249.21.2931","volume":"249","author":"A. Kemper","year":"1983","unstructured":"Kemper A., Dunlap R. and Pietro D. (1983): Thioridazine-induced Torsade de Pointes. Successful therapy with isoproterenol. J. Am. Med. Assoc.,249, 2931\u20132934.","journal-title":"J. Am. Med. Assoc."},{"key":"BF03189762_CR22","first-page":"1031","volume":"24","author":"L. Brookes","year":"1978","unstructured":"Brookes L., Chao F., Forrest I., Green D., Loeffler K. and Serra M. (1978): New metabolites of thioridazine and mesoridazine (abstract). Clin. Chem.,24, 1031.","journal-title":"Clin. Chem."},{"key":"BF03189762_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0165-6147(83)90487-X","volume":"4","author":"P. Waldmeier","year":"1983","unstructured":"Waldmeier P. (1983): Chiral antidepressants: a potential help in antidepressant and behavioural research trends in pharmacology. Trends Pharmacol. Sei.,4, 448\u2013449.","journal-title":"Trends Pharmacol. Sei."},{"key":"BF03189762_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/BF00541922","volume":"26","author":"E. Ariens","year":"1984","unstructured":"Ariens E. (1984): Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur. J. Clin. Pharmacol.,26,663\u20136688.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF03189762_CR25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1600-0773.1984.tb01932.x","volume":"54","author":"A. Jeppsson","year":"1984","unstructured":"Jeppsson A., Johansson U. and Waldeck B. (1984): Steric aspects of agonism and antagonism at \u03b2-adrenoceptors: experiments with the enantiomers of terbutaline and pindolol. Acta Pharmacol, et Toxicol.,54, 285\u2013291.","journal-title":"Acta Pharmacol, et Toxicol."},{"key":"BF03189762_CR26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3565(25)22045-6","volume":"227","author":"S. Bai","year":"1983","unstructured":"Bai S., Wilson M., Walle U. and Walle T. (1983): Stereoselective increase in propranolol bioavailability during chronic dosing in the dog. J. Pharmacol. Exp. Ther.,227, 360\u2013364.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03189762_CR27","first-page":"228","volume-title":"Lung Metabolism","author":"A. Junod","year":"1975","unstructured":"Junod A. and Rodolfe de H. (1975): Lung Metabolism, p. 228, Academic Press, New York."},{"key":"BF03189762_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000137976","volume":"28","author":"Y. Ohmiya","year":"1984","unstructured":"Ohmiya Y. and Mehendale H. (1984): Species differences in pulmonary N-oxidation of chlorpromazine and imipramine. Pharmacology,28, 289\u2013295.","journal-title":"Pharmacology"},{"key":"BF03189762_CR29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1970.01740280001001","volume":"22","author":"S. Curry","year":"1970","unstructured":"Curry S., Marshall J., Davis J. and Janowsky D. (1970a) Chlorpromazine plasma levels and effects. Arch. Gen. Psychiatry,22, 289\u2013296.","journal-title":"Arch. Gen. Psychiatry"},{"key":"BF03189762_CR30","first-page":"49","volume":"77","author":"L. Hollister","year":"1977","unstructured":"Hollister L., Curry S., Derr J. and Kanter S. (1977): Plasma levels and urinary excretion of four different dosage forms of chlorpromazine. Clin. Pharmacol. Ther.,77, 49\u201359.","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF03189762_CR31","first-page":"119","volume":"9","author":"J. Wood","year":"1979","unstructured":"Wood J., Lee A. and Garrettson L. (1979): Periodicity during the distributive phase for drugs administered intravenously to humans. Drug Metab. Rev.,9,119\u2013128.","journal-title":"Drug Metab. Rev."},{"key":"BF03189762_CR32","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2125.1976.tb00647.x","volume":"3","author":"C. Hansen","year":"1976","unstructured":"Hansen C., Christensen T., Elley J., Hansen L., Sorenson P., Larsen N., Naesoft J. and Hvidbert E. (1976): Clinical pharmacokinetic studies of perphenazine. Br. J. Clin. Pharmacol.,3, 915\u2013923.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF03189762_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jps.2600730308","volume":"73","author":"W. Colburn","year":"1984","unstructured":"Colburn W. (1984): Pharmacokinetic analysis of concent ration \u2014 time d a t a obtained following administration of drugs that are recycled in the bile. J. Pharm. Sei.,73, 313\u2013317.","journal-title":"J. Pharm. Sei."},{"key":"BF03189762_CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jat\/9.5.197","volume":"9","author":"P. Hale","year":"1985","unstructured":"Hale P. and Poklis A. (1985): Thioridazine 5-sulfoxide diastereoisomers in human serum and urine. J. Anal. Toxicol.,9, 197\u2013201.","journal-title":"J. Anal. Toxicol."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189762.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03189762\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189762.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T22:07:34Z","timestamp":1740348454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF03189762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985,10]]}},"alternative-id":["BF03189762"],"URL":"https:\/\/doi.org\/10.1007\/bf03189762","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[1985,10]]}}}